People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Other Health Care, Pharmaceuticals, Other Technology, Software / Tech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fractyl Laboratories Inc. | — | Other Health Care | Series C | $290.1M | $309.8M | 2013 |
| Orexigen Therapeutics, Inc. | — | Pharmaceuticals | Series D+ | $274.6M | $1.8B | 2015 |
| Revision Optics Inc | — | Other Technology | Series B | $121.7M | $973.8M | 2013 |
| Colorescience Inc | — | Other Health Care | Series B | $51.2M | $66.5M | 2013 |
| Miramar Labs, Inc. | — | Software / Tech | Series B | $45.6M | $75.1M | 2016 |
| Skinmedica Inc | — | Pharmaceuticals | Series B | $26.2M | $569.9M | 2009 |
| Novalar Pharmaceuticals Inc | — | Biotechnology | Seed | $1.0M | $44.4M | 2010 |
Brian H. Dovey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian H. Dovey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David F Hale | 2 | 16 |
| Brian Dovey | 2 | 7 |
| Mary Fisher | 2 | 3 |
| James H. Cavanaugh, Ph.D. | 2 | 3 |
| Theodore Ebel | 2 | 2 |
| Hemant Taneja | 1 | 21 |
| Wende Hutton | 1 | 16 |
| Ajay Royan | 1 | 13 |
| Amy Schulman | 1 | 11 |
| Alex Morgan | 1 | 10 |
| Adele Oliva | 1 | 9 |
| Stanley Lapidus | 1 | 7 |
| Louis C. Bock | 1 | 7 |
| Josh Baltzell | 1 | 7 |
| Thomas Lynch | 1 | 7 |
| Frank Fischer | 1 | 5 |
| Gilbert H. Kliman | 1 | 5 |
| Adele C. Oliva | 1 | 5 |
| Joshua J. Baltzell | 1 | 5 |
| Diane Marcou | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.